Corline Biomedical AB - ESG Rating & Company Profile powered by AI
Jump to the bottom of this page for potential risks for Corline Biomedical AB based on sector, location and size. The ESG rating covers seventeen UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Climate Action' and 'Life below Water'. The webpage contains a questions and answers section on Corline Biomedical AB.
Corline Biomedical AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1810 | XBiotech Inc | 1.1 | Low |
| 1826 | Mitsubishi Tanabe Pharma Corp | 1.0 | Low |
| 1827 | Corline Biomedical AB | 0.9 | Low |
| 1827 | CannTrust Holdings Inc | 0.9 | Low |
| 1827 | Cannabis Poland SA | 0.9 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Corline Biomedical AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Corline Biomedical AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Corline Biomedical AB report the average age of the workforce?
Sign up for free to unlockDoes Corline Biomedical AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Corline Biomedical AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Corline Biomedical AB disclose cybersecurity risks?
Sign up for free to unlockDoes Corline Biomedical AB offer flexible work?
Sign up for free to unlockDoes Corline Biomedical AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Corline Biomedical AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Corline Biomedical AB conduct supply chain audits?
Sign up for free to unlockDoes Corline Biomedical AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Corline Biomedical AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Corline Biomedical AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Corline Biomedical AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Corline Biomedical AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Corline Biomedical AB disclose water use targets?
Sign up for free to unlockDoes Corline Biomedical AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Corline Biomedical AB have a product recall in the last two years?
Sign up for free to unlockDoes Corline Biomedical AB disclose incidents of discrimination?
Sign up for free to unlockDoes Corline Biomedical AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Corline Biomedical AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Corline Biomedical AB disclose parental leave metrics?
Sign up for free to unlockDoes Corline Biomedical AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Corline Biomedical AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Corline Biomedical AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Corline Biomedical AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Corline Biomedical AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Corline Biomedical AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Corline Biomedical AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Corline Biomedical AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Corline Biomedical AB disclose its waste policy?
Sign up for free to unlockDoes Corline Biomedical AB report according to TCFD requirements?
Sign up for free to unlockDoes Corline Biomedical AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Corline Biomedical AB disclose energy use targets?
Sign up for free to unlockDoes Corline Biomedical AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Corline Biomedical AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Corline Biomedical AB
These potential risks are based on the size, segment and geographies of the company.
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.